If you need more lookups,
subscriptions start at $34 USD/month.
Stefan Kolb Location
Zürich, ZH, CH
Stefan Kolb Work
2020 -now Founder @ Curaxon Ltd
2022 -2024 Vice President - Scientific Affairs @
2022 -2022 Senior Global Medical Director - Medical Affairs @
2020 -2022 Senior Global Medical Director - Lysosomal Storage Diseases @ Orphazyme A/S
2017 -2019 Senior Global Medical Director, Specialty Care @ Janssen Pharmaceutical - Johnson & Johnson (after acquisition of Actelion)
2017 -2017 Senior Global Medical Director, Specialty Care @
2015 -2016 Senior Global Medical Director @
2008 -2014 Global Medical Director @
2006 -2008 European Medical Manager Neuroscience @
2001 -2006 Medical Advisor CNS and Endocrine Care @
1998 -2001 Head of Laboratory for Diagnostic Electronmicroscopy @ University Hospital Zurich, Department of Pathology
1996 -1998 Research Assistent @ University Hospital Zurich, Department of Internal Medicine, Division Immunology
1996 -1996 Postgraduate Course in Experimental Medicine @ University Zurich
1994 -1996 Research Assistent @ Unversity of Zurich, Department of Anatomy
Stefan Kolb Education
University of Zurich 1987-1992
Stefan Kolb Skills
Pharmaceutical Industry
Medical Affairs
Pharmacovigilance
Neuroscience
Clinical Development
Clinical Trials
Endocrinology
Immunology
Neurology
Clinical Research
Healthcare
Psychiatry
Medicine
Biotechnology
Life Sciences
Laboratory
Management
Leadership
Data Analysis
Stefan Kolb Summary
Stefan Kolb, based in Zürich, ZH, CH, is currently a Founder at Curaxon Ltd. Stefan Kolb brings experience from previous roles at Zevra Therapeutics, Orphazyme A/S and Janssen Pharmaceutical - Johnson & Johnson (after acquisition of Actelion). Stefan Kolb holds a 1987 - 1992 University of Zurich. With a robust skill set that includes Pharmaceutical Industry, Medical Affairs, Pharmacovigilance, Neuroscience, Clinical Development and more. Stefan Kolb has 1 mobile phone numbers on RocketReach.
Looking for a different Stefan Kolb?
Find contact details for 700 million professionals.